A global leader in innovative genomic
technology and diagnostic tests.

Highly recognized in the field of genomics.

Our team comprises scientists, clinicians, innovators and survivors, all dedicated to delivering breakthroughs that improve the outcomes and quality of life for patients with breast cancer. With decades of expertise Agendia is at the forefront of healthcare innovation.

Executive Management

Our founders are recognized leaders in the field of genomics. Their prominent roles at comprehensive cancer centers put Agendia in an excellent position to partner with the academic world.

Mark R. Straley

Chief Executive Officer

Kurt Becker

Chief Operating Officer

Brian Dow

Chief Financial Officer

William Audeh, MD, MS

Chief Medical Officer

Roopom Banerjee

Chief Strategy Officer & Head of Business Development

Franklin Libenson, MD, MPH

Interim, Chief Commercial Officer

Bastiaan Van Der Baan

Chief Clinical & Business Development Officer

Prof. Laura van ‘t Veer, PhD

Chief Research Officer, Co-founder

Prof. Dr. René Bernards, PhD

Chief Scientific Officer, Co-founder

Christy Garcia

Vice President, Compliance

Board of Directors

Patrick J. Balthrop

Supervisory Board Chairman

An Van Es

Supervisory Board Member

Erik Esveld

Supervisory Board Member

Françoise Ferré

Supervisory Board Member

Laurie Heilmann

Supervisory Board Member

Peter Stein

Supervisory Board Member

Christoph Waer

Supervisory Board Member